| Q36288990 | An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells |
| Q40002243 | Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation |
| Q38716171 | Betulinic Acid-Mediated Apoptosis in Human Prostate Cancer Cells Involves p53 and Nuclear Factor-Kappa B (NF-κB) Pathways. |
| Q37257659 | ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells |
| Q36409841 | Gene expression profiling identifies lobe-specific and common disruptions of multiple gene networks in testosterone-supported, 17beta-estradiol- or diethylstilbestrol-induced prostate dysplasia in Noble rats |
| Q36359259 | Initiation of prostate cancer in mice by Tp53R270H: evidence for an alternative molecular progression |
| Q33753357 | Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy |
| Q37418513 | Is EGR1 a potential target for prostate cancer therapy? |
| Q39455487 | Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo |
| Q36744765 | Prostate cancer: Re-focusing on androgen receptor signaling |
| Q37418376 | Role of p53 in the anti-proliferative effects of Sirt1 inhibition in prostate cancer cells |
| Q34577526 | Serum p53 antibody detection in patients with impaired lung function. |
| Q26783920 | Single and Multiple Gene Manipulations in Mouse Models of Human Cancer |
| Q35612785 | The TP53 Codon 72 Polymorphism and Risk of Sporadic Prostate Cancer among Iranian Patients |
| Q38859577 | The roles of microRNAs in the progression of castration-resistant prostate cancer |
| Q36247095 | The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. |
| Q40991532 | Xenotropic Murine Leukemia Virus-Related Virus and RNase L R462Q Variants in Iranian Patients With Sporadic Prostate Cancer. |
| Q42259363 | miR-30e* is overexpressed in prostate cancer and promotes NF-κB-mediated proliferation and tumor growth |
| Q39237016 | p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3. |